Revvity has announced a comprehensive initiative to expand early detection capabilities for type 1 diabetes, combining in vitro diagnostic assay development with laboratory testing services in collaboration with Sanofi. The programme centres on advancing the company’s existing research-use autoantibody testing platform towards regulatory approval and broader clinical implementation.

SPT Labtech and Agilent Technologies have announced the release of automated target enrichment protocols for the firefly®+ platform, designed to streamline genomic sequencing workflows in clinical research, oncology, and precision medicine applications. The protocols, which integrate Agilent’s SureSelect Max DNA Library Prep Kit with SPT Labtech’s liquid handling automation, are now available to all firefly+ […]

BioMed X has launched XFem Labs, a dedicated women’s health research and development accelerator at its Heidelberg facility, marking a strategic expansion of the institute’s translational research portfolio. The initiative, backed by a $2 million grant from the Gates Foundation, will focus on addressing critical gaps in women’s healthcare, with particular emphasis on accessible contraceptive […]